Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
All content for FDA Drug Information Updates is the property of ReachMD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)
FDA Drug Information Updates
15 years ago
New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)
FDA is recommending new safety measures to improve the safe use of long acting beta agonists (LABAs).
FDA Drug Information Updates
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
